# OnCo record paper-prima-rituximab-maintenance-follicular-lancet-2011 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-prima-rituximab-maintenance-follicular-lancet-2011/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-prima-rituximab-maintenance-follicular-lancet-2011" ;
  schema:name "Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial"@en ;
  schema:alternateName "PRIMA 2011"@en, "Salles 2011"@en ;
  schema:description "Two years of an antibody given every two months after first-line chemotherapy raised the proportion still free of progression at three years from 58 to 75 per cent."@en ;
  schema:url <https://onco.cc/key-papers/paper-prima-rituximab-maintenance-follicular-lancet-2011/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(10)62175-7>, <https://pubmed.ncbi.nlm.nih.gov/21176949/>, <https://europepmc.org/article/MED/21176949> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(10)62175-7> ;
  schema:datePublished "2011"^^xsd:gYear ;
  schema:author "Salles G, Seymour JF, Offner F, et al." ;
  onco:related <https://onco.cc/key-papers/paper-prima-final-rituximab-maintenance-follicular-jco-2019/>, <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/> ;
  onco:companies <https://onco.cc/companies/lysa/> ;
  onco:terms <https://onco.cc/terms/maintenance-therapy/>, <https://onco.cc/terms/lymphoma-tx-maintenance/>, <https://onco.cc/terms/flipi/> ;
  onco:trials <https://onco.cc/trials/prima-follicular/> ;
  onco:people <https://onco.cc/people/gilles-salles/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:journals <https://onco.cc/journals/lancet/> .